Subsidiaries Silence EContact Us>
Silence Therapeutics Silence Therapeutics
▼
197.00p (-8.00p)
Vol: 28175
(15-minute delayed)
View full stock quote


  • Home
  • About Us
  • Platform Technologies
  • Pipeline
  • Collaborations
  • Investor Relations
  • News & Events
  • RNAi Hub
  • Menu
  • About Us
    • Overview
    • Strategy
    • History
    • Management
    • Board Of Directors
    • Scientific Advisory Board
    • Careers
  • RNAI Platform
    • Overview
    • Delivery Platform
    • RNAi Platform
    • RNA Interference
    • Intellectual Property
    • Publications
    • Glossary
  • Pipeline
    • Overview
    • Pre-Clinical development
  • Collaborations
    • Overview
    • Silence's Strengths
    • Partnerships
    • Partnering Opportunities
  • Investor Relations
    • Overview
    • Press Releases
    • Reports and Disclosures
    • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Publications
  • RNAi Hub
  • Contact
 
 
News Events
Publications Companies
Clinical Trials  

Tag Archives: Phytochemistry

  • Suppression of camptothecin biosynthetic genes results in metabolic modification of secondary products in hairy roots of Ophiorrhiza pumila.

    0 Replies

    June 03, 2012

    Suppression of camptothecin biosynthetic genes results in metabolic modification of secondary products in hairy roots of Ophiorrhiza pumila. Phytochemistry. 2012 May 29; Authors: Asano T, Kobayashi K, Kashihara E, Sudo H, Sasaki R, Iijima Y, Aoki K, Shibata D, Saito K, Yamazaki M Abstract Camptothecin is a monoterpenoid indole alkaloid... Contine Reading & Discuss→

    Posted in :  News |  Other News |  Publications |  Syndicated |  Tagged in :  Phytochemistry | 

Sign up to receive alerts

>

Submit

ARCHIVES

Open

2013

  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
Open

2012

  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
Open

2011

  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
Open

2010

  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
Open

2009

  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
Open

2008

  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
Open

2007

  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
Open

2006

  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
Open

2005

  • December 2005
  • November 2005
  • August 2005
  • July 2005
  • June 2005
  • May 2005
  • April 2005
  • March 2005
  • February 2005
  • January 2005
Open

2004

  • October 2004
  • July 2004
  • June 2004
Open

2003

  • December 2003
  • May 2003

TAGS

Arrowhead Research Corporation Biochem Biophys Res Commun Biochim Biophys Acta Biomaterials Blood BMC Genomics BMC Plant Biol cancer Cancer Res Cell Curr Biol Dev Biol Genes Dev Genetics Industry News Insect Biochem Mol Biol Int J Oncol J Biol Chem J Cell Sci J Insect Physiol J Virol Mariana Bio Methods Mol Biol microRNA Micro RNA Blog Mirapharm mirna Mol Biol Rep Mol Cell Biol Mol Ther Mol Ther Nucleic Acids Nucleic Acids Res Oncol Rep Plant Biotechnol J Plant Physiol PLoS Genet PLoS One PLoS Pathog Proc Natl Acad Sci U S A Report Report Linker RNAi Santaris silence therapeutics Uncategorized

Quick Links

  • Home
  • About Us
  • Platform Technologies
  • Pipeline
  • Collaborations
  • Investor Relations
  • News & Events
  • RNAi HUB
  • Site Map

Contact

3 Shortlands
Hammersmith
London W6 8DA
United Kingdom


Tel:+44 (0) 333 9880 140
Fax:+44 (0) 795 731 8494
Silence Therapeutics

Copyright © 2013 Silence Therapeutics.
All rights reserved.

Terms of Use
Forward-Looking Statement